Gene · 440
Papers1,669
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,669
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7. | Cardiovasc Diabetol | 2024 | 38195542 | PubTator, text mining | PubMed |
| Transcriptome analysis in a humanized mouse model of familial dysautonomia reveals tissue-specific gene expression disruption in the peripheral nervous system. | Sci Rep | 2024 | 38177237 | PubTator, text mining | PubMed |
| The first report of a Korean/Vietnamese child with novel pathogenic variants in Asparagine Synthetase Deficiency (ASNSD) with evolving epilepsy syndromes. | Seizure | 2024 | 38043418 | Swiss-Prot, curated | PubMed |
| Activation of ATF3 via the Integrated Stress Response Pathway Regulates Innate Immune Response to Restrict Zika Virus. | bioRxiv | 2024 | 37546954 | PubTator, text mining | PubMed |
| Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors. | Antioxidants (Basel) | 2023 | 38247474 | PubTator, text mining | PubMed |
| The Cytotoxicity of Cotyledon orbiculata Aqueous Extract and the Biogenic Silver Nanoparticles Derived from the Extract. | Curr Issues Mol Biol | 2023 | 38132477 | PubTator, text mining | PubMed |
| Development of a ferroptosis-based molecular markers for predicting RFS in prostate cancer patients. | Sci Rep | 2023 | 38129557 | PubTator, text mining | PubMed |
| New insights into the correlations between circulating tumor cells and target organ metastasis. | Signal Transduct Target Ther | 2023 | 38129401 | PubTator, text mining | PubMed |
| Prenatal diagnosis of microcephaly through combined MRI and ultrasonography: Analysis of a case series. | Medicine (Baltimore) | 2023 | 38115306 | PubTator, text mining | PubMed |
| Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type. | Sci Adv | 2023 | 38091391 | PubTator, text mining | PubMed |
| Elovanoid-N34 modulates TXNRD1 key in protection against oxidative stress-related diseases. | Cell Death Dis | 2023 | 38086796 | PubTator, text mining | PubMed |
| DRP1: At the Crossroads of Dysregulated Mitochondrial Dynamics and Altered Cell Signaling in Cancer Cells. | ACS Omega | 2023 | 38075775 | PubTator, text mining | PubMed |
| Bisabosqual A: A novel asparagine synthetase inhibitor suppressing the proliferation and migration of human non-small cell lung cancer A549 cells. | Eur J Pharmacol | 2023 | 38059445 | PubTator, text mining | PubMed |
| TXNDC12 inhibits lipid peroxidation and ferroptosis. | iScience | 2023 | 38047088 | PubTator, text mining | PubMed |
| Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs. | Front Pharmacol | 2023 | 38044950 | PubTator, text mining | PubMed |
| Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies. | Front Immunol | 2023 | 38022560 | PubTator, text mining | PubMed |
| The crosstalk among the physical tumor microenvironment and the effects of glucose deprivation on tumors in the past decade. | Front Cell Dev Biol | 2023 | 38020920 | PubTator, text mining | PubMed |
| Role of epithelial-mesenchymal transition factor SNAI1 and its targets in ovarian cancer aggressiveness. | J Cancer Metastasis Treat | 2023 | 38009093 | PubTator, text mining | PubMed |
| The Effects of Deregulated Ribosomal Biogenesis in Cancer. | Biomolecules | 2023 | 38002277 | PubTator, text mining | PubMed |
| Phytochemicals Target Multiple Metabolic Pathways in Cancer. | Antioxidants (Basel) | 2023 | 38001865 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/440/papers?page=7